文献速递精神分裂症与精神病性障碍心境障碍

精神障碍中的脑微血管内皮细胞与血脑屏障功能障碍

Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders.
PubMed 文献 · Mol Psychiatry · 2023-09-20

研究利用4例精神分裂症、4例精神病性双相障碍和4例健康对照的诱导多能干细胞分化为脑微血管内皮样细胞,发现整体血脑屏障完整性和通透性无差异,但分层后存在血脑屏障缺陷亚型,表现为屏障功能降低、claudin-5减少和MMP1活性增加,且TNFα与MMP1抑制可改善。

要点

  • 精神分裂症和双相障碍的iPSC来源脑微血管内皮样细胞整体屏障功能与健康对照无差异。
  • 基于TEER异常值分析可识别出血脑屏障缺陷亚型,伴claudin-5降低和MMP1活性增加。
  • 抑制TNFα或MMP1可改善血脑屏障缺陷,提示潜在治疗靶点。

核心结论

  • 精神障碍患者来源的脑微血管内皮样细胞存在血脑屏障缺陷亚型,TNFα和MMP1是改善血脑屏障缺陷的潜在靶点。

研究设计与样本

  • 研究使用4例精神分裂症、4例精神病性双相障碍和4例健康对照的诱导多能干细胞分化为脑微血管内皮样细胞。

主要发现

  • 精神分裂症和双相障碍来源的脑微血管内皮样细胞在血脑屏障完整性或通透性上与健康对照无差异。
  • 基于TEER的异常值分析在精神分裂症和双相障碍细胞系中识别出血脑屏障缺陷组(n=3)和非缺陷组(n=5)。
  • 血脑屏障缺陷组屏障功能降低、对小分子通透性有增加趋势且claudin-5水平降低。
  • 血脑屏障缺陷组MMP1活性增加,与claudin-5降低和血脑屏障功能变差相关。
  • TNFα和MMP1抑制可改善血脑屏障缺陷组的屏障功能。

临床怎么用

  • 对精神障碍患者可考虑评估血脑屏障功能,识别血脑屏障缺陷亚型。
  • TNFα或MMP1抑制可能作为改善血脑屏障缺陷的潜在治疗策略。

局限性

  • 研究样本量小,仅纳入4例精神分裂症、4例双相障碍和4例健康对照。
  • 使用iPSC来源的脑微血管内皮样细胞模型,可能不能完全反映体内血脑屏障状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although there is convergent evidence for blood-brain barrier (BBB) dysfunction and peripheral inflammation in schizophrenia (SZ) and bipolar disorder (BD), it is unknown whether BBB deficits are intrinsic to brain microvascular endothelial cells (BMECs) or arise via effects of peripheral inflammatory cytokines. We examined BMEC function using stem cell-based models to identify cellular and molecular deficits associated with BBB dysfunction in SZ and BD. Induced pluripotent stem cells (iPSCs) from 4 SZ, 4 psychotic BD and 4 healthy control (HC) subjects were differentiated into BMEC-"like" cells. Gene expression and protein levels of tight junction proteins were assessed. Transendothelial electrical resistance (TEER) and permeability were assayed to evaluate BBB function. Cytokine levels were measured from conditioned media. BMECs derived from human iPSCs in SZ and BD did not show differences in BBB integrity or permeability compared to HC BMECs. Outlier analysis using TEER revealed a BBB-deficit (n = 3) and non-deficit (n = 5) group in SZ and BD lines. Stratification based on BBB function in SZ and BD patients identified a BBB-deficit subtype with reduced barrier function, tendency for increased permeability to smaller molecules, and decreased claudin-5 (CLDN5) levels. BMECs from the BBB-deficit group show increased matrix metallopeptidase 1 (MMP1) activity, which correlated with reduced CLDN5 and worse BBB function, and was improved by tumor necrosis factor α (TNFα) and MMP1 inhibition. These results show potential deficits in BMEC-like cells in psychotic disorders that result in BBB disruption and further identify TNFα and MMP1 as promising targets for ameliorating BBB deficits.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lizano P, Pong S, Santarriaga S, et al. Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders. Mol Psychiatry. 2023. PMID: 37730841. doi:10.1038/s41380-023-02255-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。